Recursion plans to present updated data from the TUPELO trial in an upcoming webinar scheduled for December 8, 2025. This presentation will provide further insights into the drug’s safety and efficacy ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

A Florida man with near-unmatched gumption for slaying snakes was awarded $1,000 through a new state incentive system for capturing a staggering 87 invasive pythons in just one month. Aaron Mann ...

Forget Dr. Google, Americans are turning to artificial intelligence for their health needs. According to a survey of 2,000 U.S. adults, a little more than a third (35%) already use AI to learn about ...

Among the cypress and saw grass of South Florida, a new weapon in the state's fight to remove invasive pythons lurks, waiting to entice its prey. Yes, it's a mechanical rabbit. Just don’t call it the ...

Rallybio Corporation (NASDAQ:RLYB) agreed on Tuesday to sell its interest in REV102, an ENPP1 inhibitor in preclinical development for hypophosphatasia (HPP), to joint venture partner Recursion ...

Editor’s Note: Call to Earth is a CNN editorial series committed to reporting on the environmental challenges facing our planet, together with the solutions. Rolex’s Perpetual Planet Initiative has ...